We are live on ! Find out more
CIA

Capital Impact Advisors Portfolio holdings

AUM $247M
1-Year Est. Return 31.15%
This Fund
S&P 500
This Quarter Est. Return
+46.47%
1 Year Est. Return
+31.15%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$407M
AUM Growth
+$69.8M
Cap. Flow
-$22.2M
Cap. Flow %
-5.45%
Top 10 Hldgs %
24.1%
Holding
129
New
20
Increased
20
Reduced
20
Closed
27

Top Buys

Rank Stock Value
1
VCYT icon
Veracyte
VCYT
+$8.34M
2
TWST icon
Twist Bioscience
TWST
+$6.32M
3
SGEN
Seagen Inc. Common Stock
SGEN
+$5.16M
4
PACB icon
Pacific Biosciences
PACB
+$5.1M
5
TDOC icon
Teladoc Health
TDOC
+$4.41M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$11.4M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$8.49M
3
LVGO
Livongo Health, Inc. Common Stock
LVGO
+$6.86M
4
CRSP icon
CRISPR Therapeutics
CRSP
+$5.86M
5
ARWR icon
Arrowhead Research
ARWR
+$5.76M

Sector Composition

Rank Sector Weight
1 Healthcare 45.15%
2 Technology 24.29%
3 Communication Services 9.57%
4 Consumer Discretionary 5.1%
5 Financials 4.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NBIX icon
76
Neurocrine Biosciences
NBIX
$16.8B
$2.12M 0.52%
22,106
– –
PI icon
77
Impinj
PI
$4.62B
$2.11M 0.52%
50,316
-11,700
-19% -$408K
BEAM icon
78
Beam Therapeutics
BEAM
$2.63B
$2.04M 0.5%
+25,000
New +$1.23M
KURA icon
79
Kura Oncology
KURA
$800M
$2.04M 0.5%
62,331
– –
HUYA
80
Huya Inc
HUYA
$563M
$1.99M 0.49%
+100,000
New +$2.14M
REGN icon
81
Regeneron Pharmaceuticals
REGN
$78.5B
$1.99M 0.49%
4,115
– –
SDGR icon
82
Schrodinger
SDGR
$1.13B
$1.98M 0.49%
+25,000
New +$1.57M
CLLS
83
Cellectis
CLLS
$277M
$1.9M 0.47%
+70,300
New +$1.58M
MPWR icon
84
Monolithic Power Systems
MPWR
$70.1B
$1.9M 0.47%
5,182
– –
RNG icon
85
RingCentral
RNG
$4.66B
$1.9M 0.47%
5,000
– –
VAPO
86
DELISTED
Vapotherm, Inc. Common Stock
VAPO
$1.88M 0.46%
8,750
– –
SYRS
87
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$1.83M 0.45%
16,860
– –
PNFP icon
88
Pinnacle Financial Partners Inc
PNFP
$15.9B
$1.8M 0.44%
27,994
– –
MMSI icon
89
Merit Medical Systems
MMSI
$5.08B
$1.77M 0.44%
31,915
– –
APPF icon
90
AppFolio
APPF
$6.38B
$1.74M 0.43%
9,658
– –
CSTL icon
91
Castle Biosciences
CSTL
$855M
$1.68M 0.41%
+25,000
New +$1.36M
AQB icon
92
AquaBounty Technologies
AQB
$4.66M
$1.67M 0.41%
+9,520
New +$1.06M
EGRX
93
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$1.67M 0.41%
35,815
– –
DOYU
94
DouYu International Holdings
DOYU
$139M
$1.66M 0.41%
+15,000
New +$2.03M
PFBC icon
95
Preferred Bank
PFBC
$1.24B
$1.39M 0.34%
27,585
– –
LI icon
96
Li Auto
LI
$13.4B
$1.15M 0.28%
+40,000
New +$1.1M
ACCD
97
DELISTED
Accolade Inc
ACCD
$1.11M 0.27%
+25,500
New +$1.13M
ALLO icon
98
Allogene Therapeutics
ALLO
$649M
$1.05M 0.26%
41,800
-85,396
-67% -$2.78M
HSTM icon
99
HealthStream
HSTM
$819M
$1.02M 0.25%
46,764
– –
ZM icon
100
Zoom
ZM
$28.2B
$1.01M 0.25%
3,000
– –
2 3
4
5 6

Similar funds

AI
AXS Investments Port Chester, New York $248M AUM 15.95% 1-Year Est. Return
AB
ANB Bank Denver, Colorado $247M AUM 19.59% 1-Year Est. Return
PWS
Peloton Wealth Strategists Indianapolis, Indiana $247M AUM 13.57% 1-Year Est. Return
BFM
Blacksheep Fund Management Co. Dublin, Ireland $247M AUM 8.75% 1-Year Est. Return
IFPG
Intrepid Financial Planning Group Carmel, Indiana $248M AUM 19.02% 1-Year Est. Return
SCM
Segra Capital Management Palm Beach, Florida $248M AUM 65.61% 1-Year Est. Return
GWS
Greykasell Wealth Strategies Danville, California $248M AUM 22.08% 1-Year Est. Return
MC
Mount Capital London, United Kingdom $248M AUM 4.81% 1-Year Est. Return

Capital Impact Advisors's Q4 2020 Portfolio in Review

As of Q4 2020, Capital Impact Advisors held 129 positions worth $407M, up 21% from $337M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Capital Impact Advisors withdrew a net $22.2M in Q4 2020, closing 27 positions and reducing 20 holdings. Its most notable exit was Livongo Health, Inc. Common Stock, an estimated $6.86M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 45% of assets, up from 31% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Capital Impact Advisors opened a new position in Veracyte worth $8.81M.

  • Capital Impact Advisors's largest Q4 2020 buy was Veracyte: 180,000 shares worth $8.81M.
  • Capital Impact Advisors added most to Twist Bioscience in Q4 2020, an estimated $6.32M increase.
  • Capital Impact Advisors's biggest Q4 2020 reduction was Amazon, cutting an estimated $11.4M.
  • Capital Impact Advisors fully exited Livongo Health, Inc. Common Stock in Q4 2020, selling an estimated $6.86M.
  • Capital Impact Advisors's ten largest holdings make up 24% of its $407M portfolio in Q4 2020.
  • Capital Impact Advisors opened 20 new positions and closed 27 in Q4 2020.
  • Capital Impact Advisors's portfolio value rose 21% quarter-over-quarter to $407M.

Based on Capital Impact Advisors's 13F filing for Q4 2020, filed 12 Feb 2021.